Guerbet SA (GBT)
Euronext
Real-time Data
07:00 AM
Day's Range
7.8252 wk Range
7.43Overview - GBT - Guerbet SA
Key Statistics
Valuation
Enterprise Value
418.43M
P/E (Trailing)
‪13.77‬
P/E (Forward)
‪6.46‬
PEG Ratio
‪6.46‬
Price / Sales (TTM)
‪0.12‬
Price / Book
‪0.37‬
EV / EBITDA
‪9.10‬
Profitability
Profit Margin
‪-13.56%‬
Operating Margin
‪-1.70%‬
Return on Assets
‪0.51%‬
Return on Equity
‪-34.57%‬
Ownership
Shares Outstanding
12.61M
Float
5.25M
Held by Insiders
‪63.21%‬
Held by Institutions
‪5.47%‬
Price stats
Beta
‪0.97‬
50-Day Avg
‪8.60‬
200-Day Avg
‪11.47‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Analyst Consensus
3 analysts
Average price target
‪€ 8.43‬Market Cap - GBT - Guerbet SA
Peers - GBT - Guerbet SA
Peer Comparison
Compared with companies in Medical Devices listed on Euronext.
Profile Summary - GBT - Guerbet SA
About
Guerbet SA is a French pharmaceutical group specializing in the research, development, production, and sale of contrast media for medical imaging. Founded in 1926 by André Guerbet, the company traces its roots to the discovery of Lipiodol, the first iodinated X-ray contrast agent in 1901. It offers a comprehensive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
